MYOD1 and neoplasm: Thus, in RMS, MYOD1 is prevented from binding E-boxes that enable differentiation, while maintained or redirected to stem and proliferation associated E-boxes to promote tumor survival and proliferation (MacQuarrie et al., 2013; Yang et al., 2009; Cao et al., 2010).